[1]
“BEDAQUILINE AS A MANAGEMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB): A SYSTEMATIC REVIEW AND META ANALYSIS”, JIMKI, vol. 10, no. 2, pp. 22–40, Feb. 2024, doi: 10.53366/jimki.v10i2.554.